Read + Share
Goodoory VC, Ng CE, Black CJ, Ford AC, et al. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome
in the United Kingdom. Aliment Pharmacol Ther 2022 May 1. doi: 10.1111/apt.16939.
PMID: 35491477
|
 |
|
Goodoory VC, Ng CE, Black CJ, Ford AC, et al. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome
in the United Kingdom. Aliment Pharmacol Ther 2022 May 1. doi: 10.1111/apt.16939.
PMID: 35491477
|
|
|
|